美德林医疗
MDLN
35.96
-0.61
-1.67%
美德林医疗
US · MDLN
#667 按市值排名
上市于 2025
35.96
-0.61
-1.67%
实时 - 追踪5344个代码 - 心跳于517秒前
· 2026-10-16 20:01
✦ 量化股权信号 计算方式说明
减持
- 最近一期（2026/Q3）披露持股的机构数量增加了2家。
- 机构持股总比例下降了2.9个百分点。
机构持股
- 机构持股比例
- 119.07% -2.93pp
- 机构数量
- 481 +2
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向分歧机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流入——两者方向出现分歧。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
VC/PE Fund47.31%
Mutual Fund41.56%
Sovereign Wealth Fund16.36%
Hedge Fund9.23%
Government Pension Fund1.72%
Private Company1.29%
Public Company1.17%
Individual/Insider1.11%
Family Office/Trust0.29%
主要股东 截至 2026-06-30
The Carlyle Group Inc.
21.32% · 187.08M 股
Blackstone Inc.
17.48% · 153.33M 股
GIC Private Limited
10.68% · 93.68M 股
Hellman & Friedman LLC
8.08% · 70.87M 股
FMR
5.22% · 45.76M 股
Abu Dhabi Investment Authority
4.71% · 41.36M 股
Capital Research
4.62% · 40.51M 股
Invesco Ltd.
4.30% · 37.71M 股
BlackRock
3.01% · 26.39M 股
Lone Pine Capital LLC
2.39% · 20.97M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 21次买入 · 29次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| The Carlyle Group Inc. | -- | 21.32% |
| Blackstone Inc. | -- | 17.48% |
| GIC Private Limited | -- | 10.68% |
| Charles Mills | Chairperson | 0.30% |
| Andrew Mills | Director | 0.30% |
| Patrick Healy | Independent Director | 0.18% |
| James Pigott | President | 0.14% |
| James Boyle | Chief Executive Officer | 0.06% |
| Michael Drazin | Chief Financial Officer | 0.06% |
| Douglas Golwas | Chief Commercial Officer | 0.06% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-08-18 | James Boyle | Chief Executive Officer | Other Derivative Acquisition | +764,252 | $16.49 |
| 2026-08-18 | Stephen Miller | Chief Operating Officer | Other Derivative Acquisition | +87,667 | $19.01 |
| 2026-08-13 | GIC Private Limited | -- | Open Market Disposition | -1,600,000 | $35.80 |
| 2026-08-06 | GIC Private Limited | -- | Open Market Disposition | -590,284 | $35.58 |
| 2026-08-05 | GIC Private Limited | -- | Open Market Disposition | -2,248,612 | $35.33–36.48 |
| 2026-08-05 | Mozart Holdco, Inc. | -- | Other Disposition | -500,000 | -- |
| 2026-08-05 | Mozart Holdco, Inc. | -- | Derivative Exercise and Retained | +500,000 | -- |
| 2026-06-15 | Douglas Golwas | Chief Commercial Officer | Sale to Issuer | -100,000 | -- |
| 2026-06-15 | Douglas Golwas | Chief Commercial Officer | Derivative Exercise and Sale | -100,000 | $36.60–37.05 |
| 2026-06-14 | Michael Drazin | Chief Financial Officer | Sale to Issuer | -1,889 | $36.61 |
| 2026-06-14 | Christopher Shryock | Chief Human Resources Officer | Sale to Issuer | -872 | $36.61 |
| 2026-06-14 | Alex Liberman | Chief Legal Officer | Sale to Issuer | -872 | $36.61 |
| 2026-06-14 | Amanda Laabs | Chief Product Officer | Sale to Issuer | -1,889 | $36.61 |
| 2026-06-14 | James Boyle | Chief Executive Officer | Sale to Issuer | -2,370 | $36.61 |
| 2026-06-14 | Stephen Miller | Chief Operating Officer | Sale to Issuer | -1,889 | $36.61 |
| 2026-06-14 | Douglas Golwas | Chief Commercial Officer | Sale to Issuer | -1,889 | $36.61 |
| 2026-06-14 | William Abrams | Executive Vice President of Supply Chain Solutions | Sale to Issuer | -1,308 | $36.61 |
| 2026-06-10 | Richard Galanti | Independent Director | Other Acquisition | +16,392 | -- |
| 2026-06-10 | Todd Bluedorn | Independent Director | Other Acquisition | +15,732 | -- |
| 2026-06-10 | Thomas Sweet | Independent Director | Other Acquisition | +17,800 | -- |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 20:01:10 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
美德林医疗 讨论区 0 条评论